Rozerem - MSN Newsfeeds
- Medscape News - At the time of the meeting, benzodiazepine receptor agonist (BZRA) hypnotics were the only approved insomnia medications; however, ramelteon, a melatonin receptor agonist subsequently was approved by the FDA. In recent years, there have been ...
- Variety - IN THE PAST FEW weeks, I have done something that's embarrassing for any respectable TiVo subscriber -- that is, actually watched commercials. Not all of them, mind you, but those that stood out: The Rozerem spot where an insomniac receives advice ...
- Scotsman - JACK Straw, the former foreign secretary, waded into a race and sexism row last night after admitting he asks female Muslim constituents who visit him to remove their veils. Mr Straw, who is now the Leader of the House of Commons, said it led to ...
- Forbes - Heinz Co., Hyatt Hotels, KeyBank Corp., Master Lock, Spice Islands, Ski-Doo, Takeda Pharmaceuticals' Rozerem, WellCare Health Plans and [yellow tail] wine. Cramer-Krasselt's public relations subsidiary, CKPR, is ranked among the nation's top 15 ...
- Syracuse Post-Standard - Heinz Co., Hyatt Hotels, KeyBank Corp., Master Lock, Spice Islands, Ski-Doo, Takeda Pharmaceuticals' Rozerem, WellCare Health Plans and [yellow tail] wine. Cramer-Krasselt's public relations subsidiary, CKPR, is ranked among the nation's top 15 ...
- WIS-TV - Researchers from The Johns Hopkins School of Medicine in Baltimore looked at ramelteon (Rozerem), a drug recently approved to treat insomnia. The medication works through a different pathway in the brain that involves melatonin receptors. Researchers ...
- Forbes - A new prescription sleep medication, Ramelteon, which works by mimicking melatonin, also may be worth a try, Sassower says. If sleeping problems persist for more than a few nights, consider going to the American Academy of Sleep Medicine's Web site to ...
- US News and World Report - Zero abuse. Rozerem, which became available late last month, is the first prescription sleep drug that has no potential for abuse and thus isn't listed as a controlled substance. It binds to receptors on cells in the brain's master clock, called the ...
- PR Newswire - WALTHAM, Mass., Oct. 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite a benign safety profile, Takeda's Rozerem (ramelteon), the first ...
- News.com.au - A NEW medication recently approved for insomnia treatment does not appear to have any characteristics that might lead to dependence or abuse, researchers report. The sleep aid, Rozerem (known generically as ramelteon), acts in the same way as ...
- Reuters - NEW YORK (Reuters Health) - A new medication recently approved for insomnia treatment does not appear to have any characteristics that might lead to dependence or abuse, researchers report. The sleep aid, Rozerem (known generically as ramelteon ...
- All Headline News - New York, NY (AHN)-Researchers note that a new medication, Rozerem (known generically as ramelteon), recently approved for insomnia treatment does not appear to have any characteristics that might lead to dependence or abuse. The sleep aid acts in ...
- Medscape News - NEW YORK (Reuters Health) Oct 12 - The novel MT1 and MT2 melatonin selective receptor agonist ramelteon, recently approved for insomnia treatment, does not appear to have any characteristics that might lead to its overuse, researchers report in the ...
- Science Daily - In a study of 14 adults with histories of sedative abuse, the newly approved sleep medication ramelteon does not appear to have effects that indicate potential for abuse or motor or cognitive impairment, according to a report in the October issue of ...
- MediaPost - For the first six months of this year, category spending is already at $276 million, TNS reports--with $113.8 million spent on Ambien, $161.9 million on Lunesta, and $333,000 (in print only) on Rozerem. Takeda Pharmaceutical North America started a ...
- KFVS12 - Researchers from The Johns Hopkins School of Medicine in Baltimore looked at ramelteon (Rozerem), a drug recently approved to treat insomnia. The medication works through a different pathway in the brain that involves melatonin receptors. Researchers ...
- KFVS12 - THURSDAY, Oct. 5 (HealthDay News) -- The sleep medication ramelteon (brand name Rozerem), recently approved in the United States to treat insomnia, does not appear to have potential for substance abuse or for motor or cognitive impairment, according ...
- WDAM-TV - THURSDAY, Oct. 5 (HealthDay News) -- The sleep medication ramelteon (brand name Rozerem), recently approved in the United States to treat insomnia, does not appear to have potential for substance abuse or for motor or cognitive impairment, according ...
- All Headline News - The reason ramelteon (brand name Rozerem) seemingly does not create such side effects is because it works through a different pathway in the brain - one that involves melatonin receptors - than benzodiazepines do. In a study carried out by researchers ...
- WSTM - THURSDAY, Oct. 5 (HealthDay News) -- The sleep medication ramelteon (brand name Rozerem), recently approved in the United States to treat insomnia, does not appear to have potential for substance abuse or for motor or cognitive impairment, according ...
Pages: Previous 1 2 3 4 5 Next
These articles are related to: Rozerem Claim, Rozerem Lawsuit, Rozerem Law Suit, Rozerem Law Firm, Rozerem Lawyer, Rozerem Attorney, Rozerem Side Effects Symptoms, Rozerem Trial, Rozerem Verdict, Rozerem News, Rozerem Information, Rozerem Recall Lawyers, Rozerem Warning, Rozerem Class Action, Rozerem Prescription Drug, Rozerem Medication, Rozerem Drugs, Ramelteon Claim, Ramelteon Lawsuit, Ramelteon Law Suit, Ramelteon Law Firm, Ramelteon Lawyer, Ramelteon Attorney, Ramelteon Side Effects Symptoms, Ramelteon Trial, Ramelteon Verdict, Ramelteon News, Ramelteon Information, Ramelteon Recall Lawyers, Ramelteon Warning, Ramelteon Class Action, Ramelteon Prescription Drug, Ramelteon Medication, Ramelteon Drugs






